U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ABSOLUTE
Molecular Formula C32H32F2N4O6
Molecular Weight 606.6165
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of VELSECORAT

SMILES

C[C@@H](NC(=O)C(C)(F)F)[C@@H](OC1=CC2=C(C=C1)N(N=C2)C3=CC(=CC=C3)C(=O)N[C@@H]4CCOC4)C5=CC6=C(OCCO6)C=C5

InChI

InChIKey=ZZWJKLGCDHYVMB-XGBAOLAVSA-N
InChI=1S/C32H32F2N4O6/c1-19(36-31(40)32(2,33)34)29(20-6-9-27-28(16-20)43-13-12-42-27)44-25-7-8-26-22(15-25)17-35-38(26)24-5-3-4-21(14-24)30(39)37-23-10-11-41-18-23/h3-9,14-17,19,23,29H,10-13,18H2,1-2H3,(H,36,40)(H,37,39)/t19-,23-,29-/m1/s1

HIDE SMILES / InChI

Molecular Formula C32H32F2N4O6
Molecular Weight 606.6165
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Mon Mar 31 23:35:25 GMT 2025
Edited
by admin
on Mon Mar 31 23:35:25 GMT 2025
Record UNII
P30N0911C2
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AZD-7594
Preferred Name English
VELSECORAT
INN   USAN  
Official Name English
velsecorat [INN]
Common Name English
BENZAMIDE, 3-(5-((1R,2S)-2-((2,2-DIFLUORO-1-OXOPROPYL)AMINO)-1-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)PROPOXY)-1H-INDAZOL-1-YL)-N-((3R)-TETRAHYDRO-3-FURANYL)-
Systematic Name English
VELSECORAT [USAN]
Common Name English
AZD7594
Code English
AZD 7594 [WHO-DD]
Common Name English
Code System Code Type Description
SMS_ID
300000010809
Created by admin on Mon Mar 31 23:35:25 GMT 2025 , Edited by admin on Mon Mar 31 23:35:25 GMT 2025
PRIMARY
INN
11103
Created by admin on Mon Mar 31 23:35:25 GMT 2025 , Edited by admin on Mon Mar 31 23:35:25 GMT 2025
PRIMARY
USAN
HI-159
Created by admin on Mon Mar 31 23:35:25 GMT 2025 , Edited by admin on Mon Mar 31 23:35:25 GMT 2025
PRIMARY
FDA UNII
P30N0911C2
Created by admin on Mon Mar 31 23:35:25 GMT 2025 , Edited by admin on Mon Mar 31 23:35:25 GMT 2025
PRIMARY
PUBCHEM
139593415
Created by admin on Mon Mar 31 23:35:25 GMT 2025 , Edited by admin on Mon Mar 31 23:35:25 GMT 2025
PRIMARY
CAS
1196509-60-0
Created by admin on Mon Mar 31 23:35:25 GMT 2025 , Edited by admin on Mon Mar 31 23:35:25 GMT 2025
PRIMARY
NCI_THESAURUS
C171915
Created by admin on Mon Mar 31 23:35:25 GMT 2025 , Edited by admin on Mon Mar 31 23:35:25 GMT 2025
PRIMARY
Related Record Type Details
TARGET -> AGONIST
Transrepression activity (TR), assessed as the inhibition of AP-1-mediated transcription. Efficacy, maximum response relative to Dexamethasone (100%)=107%
IC50
TARGET -> AGONIST
LPS-induced TNF-? release in peripheral blood mononuclear cells. Efficacy, maximum response relative to Dexamethasone (100%)=75%
Related Record Type Details
ACTIVE MOIETY